Diffusion Weighted Magnetic Resonance in Imaging Younger Patients With Newly Diagnosed Bone or Soft Tissue Sarcomas

NAActive, not recruitingINTERVENTIONAL
Enrollment

98

Participants

Timeline

Start Date

June 5, 2015

Primary Completion Date

November 19, 2019

Study Completion Date

April 30, 2027

Conditions
Sarcoma, BoneSarcoma, Soft TissueOsteosarcomaSarcoma, EwingRhabdomyosarcomaNon-rhabdomyosarcoma Soft-tissue Sarcoma
Interventions
PROCEDURE

Diffusion Weighted Magnetic Resonance Imaging

Diffusion weighted magnetic resonance imaging (DWI MRI) is a method that does not involve radiation and can be used to assess the primary tumor as well as to image the entire patient, from head to toe. Diffusion weighted MRI uses a strong motion probing gradient to detect the movement of water in tissue. Tissues that are composed of tightly packed cells, such as tumors, allow less water movement than tissues with loosely packed cells. As tumors respond to therapy they become necrotic and cells are less tightly packed. This change in water diffusivity can be quantitated using DWI. Therefore, DWI provides a non-invasive, non-ionizing, and quantitative method of assessing tumor response at a cellular level and does not depend on a change in tumor size

Trial Locations (1)

38105

St. Jude Children's Research Hospital, Memphis

All Listed Sponsors
lead

St. Jude Children's Research Hospital

OTHER

NCT02415816 - Diffusion Weighted Magnetic Resonance in Imaging Younger Patients With Newly Diagnosed Bone or Soft Tissue Sarcomas | Biotech Hunter | Biotech Hunter